Global Drug Detection Technologies
25 years of forensic science.
DrugLab118 develops rapid drug detection technologies that help organisations identify threats, reduce harm and make evidence-based decisions in real time. For more than two decades, we have been advancing the science of instant detection across safeguarding, public safety, law enforcement and harm reduction environments worldwide.
Making detection visible. Making safety normal. Creating a safer social society, with safer social spaces everywhere.
Drink spiking and drug-facilitated harm are a global problem — and the world is finally moving to confront it. In the UK, Parliament is creating a standalone spiking offence and the Home Office is evaluating detection kits. Institutions everywhere are being asked to demonstrate spiking safeguards for the first time.
DrugLab118 has been preparing for this moment since 2003.
Every year, close to one million people in the United Kingdom have their drinks contaminated without their knowledge or consent — a pattern mirrored in social environments around the world. The majority will never report it. Of those who do, fewer than one in four hundred will see a charge brought.
The failure is not a lack of law. Spiking is already illegal. The failure is a lack of detection infrastructure.
When there is no way to detect contamination in real time, there is no evidence. Without evidence, there are no charges. Without charges, perpetrators learn that this crime carries no meaningful risk of consequence.
DrugLab118 exists to change that calculation.
Developments in the past twelve months — led by the UK — have transformed the institutional obligation around drink spiking detection.
Parliament is legislating a standalone spiking offence for the first time. The Bill passed the House of Commons in June 2025 and is in Lords Committee stage. When enacted, it will require evidence of substance administration — making detection infrastructure the foundation of prosecution.
In a written answer to Parliament in March 2025, the Home Office confirmed it is investing in research into the accuracy and efficacy of commercially available spiking testing kits. The government is actively evaluating which products work — and which do not.
Following changes to Section 182 guidance on the Licensing Act 2003, licensing authorities are now requiring venues to demonstrate spiking safeguards. Canterbury City Council reduced a venue's operating hours for failing to meet the standard. Compliance is no longer theoretical.
A UK government working group — chaired by the Vice-Chancellor of the University of Exeter — is examining spiking on campuses. Universities that cannot demonstrate spiking prevention infrastructure are increasingly exposed on safeguarding obligations and reputational risk.
DrugLab118 was the first company to commercialise rapid drink-spiking tests built on laboratory-validated methodologies. We have been developing forensic drug detection solutions since 2003 — longer than any competitor operating in this market today.
97–100% agreement with GC/MS. Our detection technology is built on forensic chemistry and published for independent scrutiny. The Drink Detective benzodiazepine strip achieves 97–100% agreement with GC/MS laboratory analysis. Our cross-reactivity testing has evaluated over ninety non-drug compounds — with zero false positives.
More substances, more formats. The K+ colorimetric test detects all amine-based illicit substances — including cocaine, heroin, LSD, MDMA, methamphetamine and amphetamine, in addition to ketamine. Our immunoassay strip detects twenty-two benzodiazepines, including Rohypnol. Our FentanylDetective cassette detects fentanyl and nine analogues at greater than 99% reproducibility.
Built for the real world. DrugLab118 holds USA patent protection on both the DrinkDetective and DrugDetective products. We have spent 25 years refining detection technology for the environments where people are most vulnerable — not the laboratory, but the bar, the campus, the festival, and the street.
We do not ask institutions to take our word for it. DrugLab118's detection technology has been independently tested, compared against GC/MS laboratory reference methods, and reviewed by external bodies. Every claim we make is substantiated by data you can cite in procurement, reference in policy submissions, and use in evidence.
| Evidence type | DrugLab118 | Nearest competitor |
|---|---|---|
| GC/MS comparison data published | ✓ 97–100% agreement | ✗ Not published |
| Cross-reactivity testing (non-drug) | ✓ 90+ compounds, zero false positives | ✗ Not published |
| Beverage compatibility | ✓ 50+ beverages | ✗ Not published |
| Detection specificity by compound | ✓ Full table, with concentrations | ✗ Not published |
| Years operating in this market | 25 years (est. 2003) | 2–4 (post-2021 entrants) |
*Competitor data based on publicly available website information, audited March 2026.
External laboratories, customs authorities, and police forces have independently tested and reviewed DrugLab118 technology in the field.
Manufacturer's technical review of the DRUGLAB amine-detection chemistry and its performance characteristics.
Request access →Third-party laboratory evaluation of Drink Detective's detection performance, conducted independently of DrugLab118.
Request access →Field test results from the Dutch customs authority evaluating DrugLab118 detection technology in an operational setting.
Request access →Final report from the Devon & Cornwall Police drink-spiking detection trial conducted across Plymouth's night-time economy.
Request access →Forensic imaging documentation supporting the detection methodology. Available to institutional buyers on request.
Request access →We provide complete GC/MS comparison data, compound specificity tables, and beverage compatibility data for institutional evaluation.
Request the evidence pack →
Drink-spiking detection for consumers, campuses, and venues.
Surface and substance detection for law enforcement.
Rapid fentanyl detection at the point of need.
Every DrugLab118 product is available as a white-label or co-branded format for institutional distribution — already powering detection brands across three continents. We supply the forensic chemistry and the formats; you bring them to market under your own name.
Explore white label →The new spiking offence needs evidence to work. Your institution needs infrastructure.
Drink spiking disproportionately affects university-age women in social environments. The government's own university spiking working group is defining best practice. DrugLab118 provides the validated detection tools and technical evidence that procurement officers, welfare directors, and student unions need to act with confidence.
Detection for universities →Duty of care is no longer optional. Licensing compliance now requires it.
Licensing authorities are imposing requirements on venues to demonstrate spiking safeguards. A visible testing programme is both a compliance tool and a deterrent — venues with visible safety measures see measurable reductions in spiking incidents. We provide formats designed for the bar environment, with co-branding for multi-venue operators.
Detection for hospitality →Detection that feeds the evidence chain, not the bin.
DrugLab118's DrugDetective provides law enforcement with field-deployable, forensic-grade surface and substance detection. Results in seconds. No laboratory delay. The Home Office is actively researching which commercially available detection kits work — DrugLab118 is the company that publishes the data to answer that question.
Detection for government & law enforcement →DrugLab118 grew out of forensic laboratory science into a global mission — led by named scientists and advocates with the credentials to back every claim: Colin Lyon (CEO & Founder), Jim Campbell (Chief Scientific Officer) and Seymour Ferreira (Executive Director).
Whether you are evaluating a campus safety programme, assessing licensing compliance, or building an evidence base for policy — we are ready to brief you.
Request a Briefing →Or email us directly: info@druglab118.com